InflaRx Reports Third Quarter 2023 Financial Results and Pro

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , United States , Munich , Bayern , German , Nielsc Riedemann , Laurie Doyle , Regina Lutz , Thomas Taapken , Katja Arnold , Drug Administration , Inflarx Pharmaceuticals Inc , Development Of Vilobelimab , German Ministry Of Education , Mc Services , Exchange Commission , German Ministry Of Health , Development Expenses , European Medicines Agency , Nasdaq , European Union , Inflarx Stops Development Of Vilobelimab , Chief Executive Officer , Positive Topline Results , Single Ascending Dose , Phasei Trial Support Best In Class Potential , Pyoderma Gangrenosum , Authorization Application , Critically Ill , European Committee , Medicinal Products , Human Use , Emergency Use Authorization , Cutaneous Squamous Cell Carcinoma , German Ministry , Chief Financial Officer , Marketing Expenses , Administrative Expenses , Financial Result , Cash Used , Operating Activities , Capital Resources , Financial Information , Annual Report , Condensed Consolidated Statements , Comprehensive Loss , Comprehensive Income , Financial Position , Shareholder Equity , Cash Flows , Inflarx Pharmaceuticals , Ann Arbor , German Federal Government ,